PERGOLIDE Gene Set

Dataset DGIdb Drug Targets 2026
Category physical interactions
Type drug
Description A diamine that is ergoline in which the beta-hydrogen at position 8 is replaced by a (methylthio)methyl group and the hydrogen attached to the piperidine nitrogen (position 6) is replaced by a propyl group. A dopamine D2 receptor agonist which also has D1 and D2 agonist properties, it is used as the mesylate salt in the management of Parkinson's disease, although it was withdrawn from the U.S. and Canadian markets in 2007 due to an increased risk of cardiac valve dysfunction. (Chemical Entities of Biological Interest Ontology, CHEBI_63617)
External Link https://dgidb.org/results?searchType=drug&searchTerms=PERGOLIDE
Similar Terms
Downloads & Tools

Genes

15 interacting proteins for the PERGOLIDE drug from theDGIdb Drug Targets 2026 dataset.

Symbol Name Standardized Value
DRD1 dopamine receptor D1 0.096945
DRD5 dopamine receptor D5 0.084019
DRD2 dopamine receptor D2 0.063582
DRD4 dopamine receptor D4 0.0446683
ADRA2B adrenoceptor alpha 2B 0.038778
HTR1D 5-hydroxytryptamine (serotonin) receptor 1D, G protein-coupled 0.0345961
HTR1B 5-hydroxytryptamine (serotonin) receptor 1B, G protein-coupled 0.0329794
DRD3 dopamine receptor D3 0.0301607
HTR2B 5-hydroxytryptamine (serotonin) receptor 2B, G protein-coupled 0.0299051
ADRA2A adrenoceptor alpha 2A 0.0299051
ADRA2C adrenoceptor alpha 2C 0.0286894
HTR2C 5-hydroxytryptamine (serotonin) receptor 2C, G protein-coupled 0.0243365
HTR1A 5-hydroxytryptamine (serotonin) receptor 1A, G protein-coupled 0.0210048
HTR2A 5-hydroxytryptamine (serotonin) receptor 2A, G protein-coupled 0.0161872
CYP3A4 cytochrome P450, family 3, subfamily A, polypeptide 4 0.00398284